Home Title

Transforming lives by breaking new ground in immunology treatment through specialist expertise

Transforming lives by breaking new ground in immunology treatment through specialist expertise

Transforming lives by breaking new ground in immunology treatment through specialist expertise.

Information on our 2024 AGM

AGM information
£55.2m Revenue (2023: £59.6m)
£(11.1)m Operating loss excluding R&D and exceptionals (2023: £(14.8)m)
£(40.2)m Net loss after tax (2023: £(43.1)m)

Take your career to new heights

Career Vacancies